Campaign: Areas of Interest for Cancer Nanotechnology

Therapeutic compound trafficking

Therapeutic compounds (TA) upon entering the systemic circulation undergo various clearance processes, which hinder the activity of the drug by either decreasing the amount of drug that reaches the site of action or by causing toxic side effects in various vital organs. To avoid this and to make sure the TA reaches the target site, a composite system could be composed that protects the TA from the clearance processes ...more »

Submitted by

Voting

1 vote
2 up votes
1 down votes
Active

Campaign: Areas of Interest for Cancer Nanotechnology

Improving Tumor Targeting

Many of the current targeting approaches (antibody/Fab, etc.,) are dependent on the EPR (enhanced permeability and retention) effect and not designed to increase extravasation of nanomedicines from the systemic circulation to extracellular space around tumors. The use of current strategies, e.g., Her2, folate, etc., increase intracellular uptake, but have not had widespread success at increasing total tumor deposition ...more »

Submitted by

Voting

9 votes
9 up votes
0 down votes
Active